Page 52 - TD-1-2

Tumor Discovery Aggressive sebaceous carcinoma of the scalp

clinical and histopathological findings in light of its rarity 116(2):195–198.
and aggressive behavior. 4. Bassetto F, Baraziol R, Sottosanti MV, et al., 2004, Biological
behavior of the sebaceous carcinoma of the head. Dermatol
Acknowledgments Surg, 30(3): 472–476.
None. 5. Dores GM, Curtis RE, Toro JR, et al., 2008, Incidence of
cutaneous sebaceous carcinoma and risk of associated
Funding neoplasms: Insight into Muir-Torre syndrome. Cancer,
None. 113(12): 3372–3381.
6. Dasgupta T, Wilson LD, Yu JB, 2009, A retrospective review
Conflict of interest of 1349 cases of sebaceous carcinoma. Cancer, 115(1):
158–165.
The authors declare no conflicts of interest.
7. Nguyen CV, Gaddis KJ, Stephens MR, et al., 2020, An
Author contributions intrapatient concordance study of mismatch repair protein
immunohistochemical staining patterns in patients with
Conceptualization: Sunil V. Jagtap Muir-Torre syndrome. JAMA Dermatol, 156(6): 676–680.
Supervision: Sunil V. Jagtap
Investigation: Sunil V. Jagtap, Swati S. Jagtap, and Shefali 8. Misago N, Mihara I, Ansai SI, et al., 2002, Sebaceoma
and related neoplasms with sebaceous differentiation:
Mishra A clinicopathologic study of 30 cases. Am J Dermatopathol,
Writing – original draft: Sunil V. Jagtap and Swati S. Jagtap 24(4): 294–304.
Writing – review & editing: Sunil V. Jagtap, Swati S. Jagtap,
Shefali Mishra, Kaushiki Varshney, and Shuchita Gaur 9. Bailet JW, Zimmerman MC, Arnstein DP, et al., 1992,
Sebaceous carcinoma of the head and neck. Case report and
Ethics approval and consent to participate literature review. Arch Otolaryngol Head Neck Surg, 118(11):
1245–1249.
Not applicable.
10. Jagtap SV, Kumbhar S, Mane A, et al., 2019, Basal cell carcinoma
Consent for publication of eyelid. IP Arch Cytol Histopathol Res, 4(1): 102–104.
11. Cardesa A, Nadal A, Alos L, et al., 2018, Sebaceous
Not applicable. differentiation in squamous cell carcinoma of the larynx and
Availability of data adjacent pharynx: Case report with review and discussion of
the literature. Head Neck Pathol, 12(1): 118–122.
The data can be requested from the corresponding author 12. Mulay K, White VA, Shah SJ, et al., 2014, Sebaceous
following reasonable reason. carcinoma: Clinicopathologic features and diagnostic role
of immunohistochemistry (including androgen receptor).
References Can J Ophthalmol, 49(4): 326–332.
1. Duman DG, Ceyhan BB, Celikel T, et al., 2003, Extraorbital 13. Marijon P, Bertolus C, Foy JP, et al., 2020, Custom surgical
sebaceous carcinoma with rapidly developing visceral management of invasive malignant tumors of the scalp. Acta
metastasis. Dermatol Surg, 29(9): 987–989. Neurochir (Wien), 162(12): 2991–2999.
2. Moreno C, Jacyk WK, Judd MJ, et al., 2001, Highly aggressive 14. Orcurto A, Gay BE, Sozzi WJ, et al., 2014, Long-term
extraocular sebaceous carcinoma. Am J Dermatopathol, remission of an aggressive sebaceous carcinoma following
23(5): 450–455. chemotherapy. Case Rep Dermatol, 13;6(1): 80–84.
3. Margo CE, Mulla ZD, 1998, Malignant tumors of the eyelid: 15. Bhavarajua VM, Shamim SE, Naik VR, et al., 2007, Sebaceous
A population-based study of non-basal cell and non- cell carcinoma of scalp-a rare presentation. Malays J Med
squamous cell malignant neoplasms. Arch Ophthalmol, Sci, 14(1): 67–70.

Volume 1 Issue 2 (2022) 4 https://doi.org/10.36922/td.v1i2.203